Skip to main content
Premium Trial:

Request an Annual Quote

'An Extremely Foul Technique'

If you feel like depressing yourself today, check out this blog post from Derek Lowe at In the Pipeline. Lowe points to an analysis performed on a clinical trial for gabapentin (marketed by Pfizer under the name Neurontin) in the '90s. "The authors find, by analyzing a large trove of documents released during lawsuit discovery proceedings, that [the clinical trial] was not really intended to be a clinical trial. Instead, it was a marketing program," Lowe writes. The study seems to have been unblinded and uncontrolled, he notes, adding: "This is an extremely foul technique, which brings the companies who use it, the entire drug industry, and the whole idea of clinical research into disrepute."

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.